CAM
Cozad Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-320
| Closed | -$203K | – | 413 |
|
|
2025
Q1 | $203K | Sell |
320
-2,953
| -90% | -$1.87M | 0.02% | 381 |
|
|
2024
Q4 | $2.33M | Sell |
3,273
-144
| -4% | -$103K | 0.22% | 113 |
|
|
2024
Q3 | $3.59M | Sell |
3,417
-34
| -1% | -$35.7K | 0.34% | 79 |
|
|
2024
Q2 | $3.63M | Buy |
3,451
+30
| +0.9% | +$31.5K | 0.36% | 71 |
|
|
2024
Q1 | $3.29M | Sell |
3,421
-220
| -6% | -$212K | 0.34% | 77 |
|
|
2023
Q4 | $3.2M | Sell |
3,641
-170
| -4% | -$149K | 0.37% | 76 |
|
|
2023
Q3 | $3.14M | Sell |
3,811
-3,275
| -46% | -$2.7M | 0.41% | 63 |
|
|
2023
Q2 | $5.09M | Sell |
7,086
-2,120
| -23% | -$1.52M | 0.64% | 38 |
|
|
2023
Q1 | $7.56M | Buy |
9,206
+1,190
| +15% | +$978K | 1% | 25 |
|
|
2022
Q4 | $5.78M | Buy |
8,016
+3,016
| +60% | +$2.18M | 0.81% | 35 |
|
|
2022
Q3 | $3.44M | Buy |
5,000
+1,620
| +48% | +$1.12M | 0.56% | 48 |
|
|
2022
Q2 | $2M | Buy |
3,380
+500
| +17% | +$296K | 0.31% | 98 |
|
|
2022
Q1 | $2.01M | Buy |
2,880
+250
| +10% | +$175K | 0.28% | 101 |
|
|
2021
Q4 | $1.66M | Buy |
+2,630
| New | +$1.66M | 0.24% | 111 |
|